Immunic Inc. buy Brookline Capital Management
Start price
05.04.24
/
50%
€1.27
Target price
05.04.25
€9.25
Performance (%)
-28.99%
End price
06.04.25
€0.90
Summary
This prediction ended on 06.04.25 with a price of €0.90. The prediction for Immunic Inc. disappointed with a performance of -28.99%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunic Inc. | -22.364% | -22.364% | 2.644% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten